PF4 and hepatocellular carcinoma: Comparison of individual ROC AUCs showed no significant differences (p > 0.05, DeLong et al.)between IL-6, TNF-α, and PF-4, as well as among IL-8, PF-4, and HCC-1, outlining them as evenly suitable biomarker candidates.